Claim/exemption information - Registry number 11201

Case number
2020-011225
Claimant name
Halliburton Canada ULC
Product identifier
MC C-6895
Claim type
Original
Date of filing
Claim validity status
Partially Valid
Claim validity decision date
Exemption expiry date
Non-compliance(s) identified on SDS and/or label
Yes, Order issued
SDS and/or label compliance review decision date
Claim/exemption status
Active

Additional information

Date of the order
Order status
Resolved
Date resolved

List of suggested corrective measures

  • Correct administrative non-compliances.

  • Correct the disclosure of misleading information regarding the LD50/LC50 values.

  • Correct the disclosure of misleading information regarding “Flammability (solid, gas)”.

  • Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

  • Disclose information that reflects the relevant and appropriate conditions for safe storage, including any incompatibilities.

  • Disclose information that reflects the relevant and appropriate precautions for safe handling.

  • Disclose the additional information elements concerning the hazard and precautionary statements.

  • Disclose the calculated product oral and inhalation ATE values.

  • Disclose the common names and synonyms for the mixture.

  • Disclose the conditions for safe storage, including any incompatibilities.

  • Disclose the hazard classifications of “Specific Target Organ Toxicity – Repeated Exposure – Category 1 (Mortality)”, “Specific Target Organ Toxicity – Repeated Exposure – Category 2 (Mortality)” and “Specific Target Organ Toxicity – Single Exposure – Category 3 (Eye, CNS, Blood, Narcotic Effects)”.

  • Disclose the percent of unknown toxicity for the calculated product oral and inhalation ATE values.

  • Disclose the reference to the SDS section where the applicable information can be found.

Date modified: